We reveal that it is mediated by a significant increase in chromatin accessibility at CD47 prmoter region, including elevated levels of epigenetic histone modifications at H3K4Me3 residues, in melanoma but not in normal melanocytes or HepG2 cells which are known for low CD47 expression. This evidence concerns the gene CD47 and melanoma.